Focused on improving respiratory health, Loncom Pharmaceutical's Respiratory System APIs include a range of compounds designed for the effective treatment of pulmonary diseases. These APIs are formulated to provide relief and improve quality of life for patients suffering from asthma, COPD, and other respiratory disorders, underlining our commitment to respiratory care.
Shandong Loncom Pharmaceutical Co., Ltd is founded in 2012, located in Qihe Economic Development Zone, Shandong Province, with a registered capital of 60 million yuan.
